News Releases

2011
2010
2009
2008
2007
2006
2005
2004

 

Dec 28, 2011 Protox Therapeutics Announces Closing of Additional CDN $8.3M Investment By Warburg Pincus

 

Dec 23, 2011 Protox Therapeutics Announces Additional CDN $8.3M Investment by Warburg Pincus

 

Dec 22, 2011 Protox Completes Dosing of Second Cohort of Patients in Transrectal Study

 

Dec 12, 2011 Protox Therapeutics Appoints Richard Yocum as Chief Medical Officer

 

Nov 14, 2011 Protox Reports Third Quarter 2011 Financial Results and Achievements

 

Oct 20, 2011 Protox Announces the Dosing of Patients in Transrectal Study

 

Oct 11, 2011 Protox Therapeutics Appoints Alexander Casdin as Chief Financial Officer

 

Aug 10, 2011 Protox reports second quarter 2011 financial results and achievements

 

July 18, 2011 Protox Secures $15 Million Financing from Oxford Finance LLC

 

June 6, 2011 Protox Announces Details of 2011 Annual Shareholder Meeting

 

June 2, 2011 Protox Reports First Quarter 2011 Financial Results and Achievements

 

April 18, 2011 Protox Announces Move to San Diego and Senior Management Transition

 

March 31, 2011 Protox Reports 2010 Financial Results and Achievements

 

February 22, 2011 Protox Appoints New Directors

What's New

December 28, 2011
Protox Therapeutics Announces Closing of Additional CDN $8.3M Investment By Warburg Pincus

December 23, 2011
Protox Therapeutics Announces Additional CDN $8.3M Investment by Warburg Pincus

December 22, 2011
Protox Completes Dosing of Second Cohort of Patients in Transrectal Study

 

 

 

Events

November 17, 2010
- 11:15 am ET
Protox Presents at Dundee Emerging Growth Conference

 

Stock Quote

LAST TRADE:$0.35
TRADE TIME:3:49PM EST
CHANGE:$0.02 (6.06%)
PREV CLOSE: $0.33
OPEN:$0.335
BID:$0.34
ASK:$0.35